Commonwealth Bank of Australia’s Abiomed Inc ABMD Stock Holding History

Commonwealth Bank of Australia’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-78	Closed	-$19K	–	1040
2019 Q2	$19K	Buy	78 +41	+111%	+$10.9K	﹤0.01%	1049
2019 Q1	$10K	Buy	37 +4	+12%	+$1.33K	﹤0.01%	1091
2018 Q4	$10K	Buy	+33	New	+$11.5K	﹤0.01%	1087
2013 Q3	–	Sell	-6,367	Closed	-$137K	–	1303
2013 Q2	$137K	Buy	+6,367	New	+$128K	﹤0.01%	1151

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Commonwealth Bank of Australia's ABMD Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 78 shares — an estimated $19K sold.

Commonwealth Bank of Australia first reported a position in ABMD in Q2 2013 and held it in 4 quarters. The position peaked at $137K in Q2 2013. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 78 Abiomed Inc shares in Q3 2019, an estimated $19K.
Commonwealth Bank of Australia first reported a position in Abiomed Inc in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's Abiomed Inc position peaked at $137K in Q2 2013.
443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.